OncoNano is harnessing the power of nanotechnology to unlock a new era of targeted therapeutics. Our ON-BOARD™ polymeric micelle platform exploits the highly acidic tumor microenvironment, a byproduct of cancer metabolism, to precisely deliver therapeutic payloads directly to the tumor site. OncoNano’s product candidates are designed to improve the pharmacokinetic and pharmacodynamic properties of various payloads from small molecules to large biologics through encapsulation and localized tumor targeting.
OncoNano is passionate about generating a robust oncology pipeline to advance more precise therapies and better patient outcomes. Learn more about our platform and pipeline at www.OncoNano.com.
Company Details
- Employees
- 23
- Address
- 181 Grand Avenue,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- onconanomed.com
- HQ
- Southlake, Texas
Onconano Medicine, Inc. Questions
Onconano Medicine, Inc.'s website is onconanomed.com
Onconano Medicine, Inc.'s LinkedIn profile is https://www.linkedin.com/company/onconano-medicine
Onconano Medicine, Inc. has
23 employees.
View email and phone details for 23
employees at Onconano Medicine, Inc..
Onconano Medicine, Inc.'s industry is
Biotechnology Research
Onconano Medicine, Inc.'s top competitors are
Arcus Biosciences,
Recode Therapeutics,
Cage Bio Inc.,
Taysha Gene Therapies,
Zs Pharma, Inc.,
Nanoscope Therapeutics Inc.,
Ocugen,
Gilead Sciences,
Altesa Biosciences, Inc.,
Renibus Therapeutics Inc.
Onconano Medicine, Inc.'s categories are Biotechnology Research
